1. Home
  2. MRCC vs CBUS Comparison

MRCC vs CBUS Comparison

Compare MRCC & CBUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Monroe Capital Corporation

MRCC

Monroe Capital Corporation

HOLD

Current Price

$6.67

Market Cap

151.2M

Sector

Finance

ML Signal

HOLD

Logo Cibus Inc.

CBUS

Cibus Inc.

HOLD

Current Price

$1.61

Market Cap

69.9M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
MRCC
CBUS
Founded
2011
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Agricultural Chemicals
Sector
Finance
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
151.2M
69.9M
IPO Year
2012
2017

Fundamental Metrics

Financial Performance
Metric
MRCC
CBUS
Price
$6.67
$1.61
Analyst Decision
Hold
Strong Buy
Analyst Count
1
2
Target Price
$8.00
$20.00
AVG Volume (30 Days)
102.5K
169.0K
Earning Date
11-05-2025
11-13-2025
Dividend Yield
15.02%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$43,742,000.00
$3,794,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$109.96
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.86
$1.09
52 Week High
$8.85
$4.24

Technical Indicators

Market Signals
Indicator
MRCC
CBUS
Relative Strength Index (RSI) 55.06 57.01
Support Level $6.65 $1.50
Resistance Level $6.80 $1.75
Average True Range (ATR) 0.14 0.14
MACD 0.06 0.04
Stochastic Oscillator 81.30 69.23

Price Performance

Historical Comparison
MRCC
CBUS

About MRCC Monroe Capital Corporation

Monroe Capital Corp is a speciality finance company focused on providing financing to lower middle-market companies, in the U.S. and Canada. The company provides customized financing solutions focused on senior, unitranche, and junior secured debt and unsecured subordinated debt and equity, including equity co-investments in preferred and common stock and warrants.

About CBUS Cibus Inc.

Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.

Share on Social Networks: